Cifuentes SG, Trostle J, Trueba G, et al. Transitioning cause of fever from malaria to dengue, northwestern Ecuador, 1990-2011. Emerg Infect Dis 2013 (published online Aug 12)
Dayan GH, Thakur M, Boaz M, et al. Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA. Vaccine 2013 Oct 17;31(44):5047-54
Hernandez-Avila JE, Rodriguez MH, Santos-Luna R, et al. Nation-wide, web-based, geographic information system for the integrated surveillance and control of dengue fever in Mexico. PLoS One 2013 Aug 6;8(8):e70231
Hss A-S, Koh M-T, Tan KK, et al. Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized placebo-controlled, phase III study. Vaccine 2013 (published online Oct 14)
Madani RA, Abuelzein ET, Al-Bar H, et al. Outbreak of viral hemorrhagic fever caused by dengue virus type 3 in al-Makalla, Yemen. BMC Infect Dis 2013 Mar 14;13:136
Murray KO, Rodriguez LF, Herrington E, et al. Identification of dengue fever cases in Houston, Texas, with evidence of autochthonous transmission between 2003 and 2005. Vector Borne Zoonotic Dis 2013 (published online Oct 9)
Sam SS, Omar SFS, Teoh BT, et al. Review of dengue hemorrhagic fever fatal cases seen among adults: a retrospective study. PLoS Negl Trop Dis 2013 May 2;7(5):e2194
Schwarz NG, Girmann M, Randriamampionona N, et al. Seroprevalence of antibodies against chikungunya, dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar. Emerg Infect Dis 2012 Nov;18(11):1780-6
Texas worked with northern Mexican states to monitor increasing cases of dengue fever and create a response guide that includes case definitions, statutory authority citations, a protocol for mosquito surveillance and vector control, recommended information/education, and state contact information.
